All articles by Srivani Venna

  1. Biocartis and AstraZeneca partner on lung cancer diagnostics

    Molecular diagnostics company Biocartis Group has signed an agreement with AstraZeneca to obtain faster lung cancer molecular diagnostic biomarker results…
    Read More…

    30 Nov
  2. Quidel receives CE Mark for diagnostic assay TriageTrue

    Diagnostic testing solutions provider Quidel has received a CE Mark for its diagnostic assay TriageTrue High Sensitivity Troponin I Test…
    Read More…

    30 Nov
  3. Generex to acquire 51% stake in Olaregen Therapeutix

    Generex Biotechnology has signed a letter of intent to acquire a 51% stake in US-based regenerative medicine company Olaregen Therapeutix….
    Read More…

    29 Nov
  4. Study shows patients can assess back pain using app

    A new study by the University of Warwick in the UK has revealed that patients will be able to self-assess…
    Read More…

    29 Nov
  5. UK researchers develop nanoscale blood test for cancer discoveries

    Researchers from the University of Manchester in the UK have developed a new nanoscale blood test technique for obtaining more…
    Read More…

    29 Nov
  6. SafeHeal reports positive results from clinical study of Colovac device

    French medical device company SafeHeal has reported positive results from a clinical study conducted for its Colovac bypass sheath in…
    Read More…

    27 Nov
  7. NanoGenics’ LipTide-ECP105 improves glaucoma surgery outcomes

    Scottish biotechnology company NanoGenics has announced that its gene therapy technology LipTide-ECP105 significantly improves the outcomes of glaucoma surgery. The…
    Read More…

    27 Nov
  8. Intelerad acquires Clario for medical imaging diagnostic solutions

    Intelerad Medical Systems has announced the acquisition of US-based zero-footprint worklist company Clario Medical to offer medical imaging diagnostic solutions….
    Read More…

    26 Nov
  9. MIMOS to launch non-invasive glucometer to screen blood glucose

    Malaysian national applied research and development agency, MIMOS, is set to unveil the world’s first clinically-tested non-invasive glucometer for blood…
    Read More…

    23 Nov
  10. Altus Capital buys spinal implants manufacturer ChoiceSpine

    Private equity firm Altus Capital Partners has acquired specialised spinal implants manufacturer ChoiceSpine for an undisclosed sum. ChoiceSpine also designs…
    Read More…

    21 Nov

Go Top